CyberKnife was developed at Stanford University
In 1994, CyberKnife developed by John Adler, MD and colleagues at Stanford University. CyberKnife’s special quality is that…
FDA approved Risperidone for use as atypical antipsychotic medication
On Dec. 29, 1993, the U.S. Food and Drug Administration (FDA) approved indications for oral risperidone (tablets, oral…
Francisco Mojica characterized CRISPR
On Aug. 9, 1993, Francisco Mojica published “Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially…
Diagnostics | Energy | Genomics | Life Science News | Medical Device | Nanotechnology | Non-Profit Research | Therapeutics
Martin Marietta assumed the Sandia management contract
On Jul. 25, 1993, Sandia Corp. became a Martin Marietta company, leaving the AT&T fold for the first…
Chiron’s Betaseron was approved as the first treatment for multiple sclerosis in 20 years
On Jul. 23, 1993, Chiron and Berlex Laboratories announced that the U.S. Food and Drug Administration (FDA) had…
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Betaseron, the first of several biotechnology…
ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam Plant building
On May 13, 1993, ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam…
CDC reponded to E. coli Outbreak from Hamburgers in Western United States
On Apr. 16, 1993, the U.S. Centers for Disease Control (CDC) reported that from November 15, 1992, through…
Biotechnology | Chemical | Disease | FDA | Life Science News | Therapeutics
The Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established
On Apr. 14, 1993, the Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established…
The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
The Pappajohn Clinical Cancer Center opens for service
In 1993, the John and Mary Pappajohn Clinical Cancer Center opened for service after receiving a generous $25…
The Prostate, Lung, Colorectal, and Ovarian trial began recruiting 148,000 men and women, ages 55-74
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched The trial was designed to determine whether…
Stanford Medicine researchers demonstrated that lifestyle changes and drug therapy decrease heart attack rates
In 1993, Stanford Medicine researchers led by William Haskell demonstrated that lifestyle changes and drug therapy decrease heart…
UCSF discovered genes that double lifespan of C. elegans, linked to longevity in other species
In 1993, University of California, San Francisco (UCSF) researchers Cynthia Kenyon and colleagues’ announced they had discovered that…
The CDC responded to H5N1 avian flu outbreak in China
In 1993, the U.S. Centers for Disease Control and Prevention (CDC) responded to the H5N1 avian flu outbreak…
Cook County Hospital’s HIV/AIDS clinic was re-named the Sable/Sherer Clinic
In 1993, Cook County Hospital’s HIV/AIDS clinic was re-named the Sable/Sherer Clinic. The clinic treated one-third of Cook…
VEGF molecule was discovered
In 1993, Massachusetts Eye and Ear researchers discovered the Vascular endothelial growth factor (VEGF) molecule, implicated in diabetic…
Co-discovery of microRNAs
In 1993, Harvard Medical School Genetics researcher Gary Ruvkun co-discovered small regulatory RNAs (microRNAs), which led to RNA…
Baim Institute for Clinical Resarch was founded
In 1993, the Baim Institute was first founded as the Cardiovascular Data Analysis Center (CDAC) by Donald S….
Washington University School of Medicine announced as a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study)
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
Drs. Joan and Ron Conaway at the OMRF discovered Elongin a genetic transcription factor
In 1993, Drs. Joan and Ron Conaway from the Oklahoma Medical Research Foundation (OMRF) discovered Elongin A (EloA)…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
The Physicians Pavilion opened at OHSU on Marquam Hill to provide modern outpatient services
In 1993, the Physicians Pavilion at Oregon Health & Science University (OHSU) opened on Marquam Hill to provide…
Oregon Health Policy Institute, an interdisciplinary center of OHSU, Portland State University and Oregon State University was created
In 1993, Oregon Health Policy Institute, an interdisciplinary center of Oregon Health & Science University (OHSU), Portland State…
The Hollings Cancer Center was founded
In 1993, The Hollings Cancer Center (HCC) was formally was established and named for former U.S. Senator and…
Vanderbilt Cancer Center was established
In 1993, the Vanderbilt Cancer Center was established under the leadership of Dr. Hal Moses, to bring together…
The Cancer Therapy & Research Center at San Antonio received NCI designation
In 1993, The Cancer Therapy & Research Center (CTRC) at San Antonio received National Cancer Institute (NCI) designation….
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Jon M and Karen Huntsman donated $10 million to the University of Utah to establish a cancer institute
In 1993, Jon M. and Karen Huntsman donated $10 million to the University of Utah to establish a…
Immunex merged with American Cyanamid’s Lederle Oncology business
On Dec. 21, 1992, Immunex announced a merger agreement with American Cyanamid Company’s Lederle Oncology business. In Nov….
Targeted Genetics began human clinical testing using gene therapy to combat HIV infection
In 1993, Targeted Genetics, a subsidiary of the Immunex Corporation, became the first company to begin human clinical…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Taxol (paclitaxel) approved by the FDA for the treatment of ovarian cancer that has failed other therapy
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…